| Overview |
| bs-2643R-FITC |
| KIR2DL4 Polyclonal Antibody, FITC Conjugated |
| WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CD158 |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3805 |
| Q99706 |
| Cell membrane |
| G9P; CD158D; KIR103; KIR103AS; KIR-103AS; Killer cell immunoglobulin-like receptor 2DL4; CD158 antigen-like family member D; Killer cell inhibitory receptor 103AS; MHC class I NK cell receptor KIR103AS; KIR2DL4 |
| Receptor on natural killer (NK) cells for HLA-C alleles. Inhibits the activity of NK cells thus preventing cell lysis. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |